BIMASONE Trademark

Trademark Overview

On Monday, March 8, 2021, a trademark application was filed for BIMASONE with the United States Patent and Trademark Office. The USPTO has given the BIMASONE trademark a serial number of 90566093. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Wednesday, January 15, 2025. This trademark is owned by BIMEDA Animal Health Limited. The BIMASONE trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary pharmaceutical preparations and substances containing flumethasone for the treatment of inflammatory conditions and musculoskeletal disorders; anti-inflammatory veterinary pharmaceutical preparations and substances for the treatment of inflammatory conditions and musculoskeletal disorders; anti-inflammatories, namely, corticosteroids; veterinary pharmaceutical preparations and substances used in the treatment of inflammatory conditions and musculoskeletal disorders
bimasone

General Information

Serial Number90566093
Word MarkBIMASONE
Filing DateMonday, March 8, 2021
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateWednesday, January 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 16, 2021

Trademark Statements

Goods and ServicesVeterinary pharmaceutical preparations and substances containing flumethasone for the treatment of inflammatory conditions and musculoskeletal disorders; anti-inflammatory veterinary pharmaceutical preparations and substances for the treatment of inflammatory conditions and musculoskeletal disorders; anti-inflammatories, namely, corticosteroids; veterinary pharmaceutical preparations and substances used in the treatment of inflammatory conditions and musculoskeletal disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 7, 2021
Primary Code005
First Use Anywhere DateTuesday, April 30, 2024
First Use In Commerce DateTuesday, April 30, 2024

Trademark Owner History

Party NameBIMEDA Animal Health Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDublin D18K8Y4
IE
Party NameBIMEDA Animal Health Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDublin D18K8Y4
IE

Trademark Events

Event DateEvent Description
Thursday, March 11, 2021NEW APPLICATION ENTERED
Monday, June 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 29, 2021ASSIGNED TO EXAMINER
Thursday, October 14, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, October 14, 2021EXAMINERS AMENDMENT E-MAILED
Thursday, October 14, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 14, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, October 14, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, July 6, 2022SOU EXTENSION 1 FILED
Wednesday, July 6, 2022SOU EXTENSION 1 GRANTED
Friday, July 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 12, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 12, 2022SOU EXTENSION 2 FILED
Monday, December 12, 2022SOU EXTENSION 2 GRANTED
Wednesday, December 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 20, 2023SOU EXTENSION 3 FILED
Tuesday, June 20, 2023SOU EXTENSION 3 GRANTED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 8, 2024SOU TEAS EXTENSION RECEIVED
Monday, January 8, 2024SOU EXTENSION 4 FILED
Monday, January 8, 2024SOU EXTENSION 4 GRANTED
Wednesday, January 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, July 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 11, 2024SOU EXTENSION 5 FILED
Tuesday, October 29, 2024USE AMENDMENT FILED
Tuesday, October 29, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, January 15, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 15, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 11, 2024SOU EXTENSION 5 GRANTED

Related Keywords

bimasone inflammatory veterinary pharmaceutical musculoskeletal disorders treatment conditions preparations substances anti